BioCentury
ARTICLE | Company News

Biotest, Kedrion deal

February 8, 2016 8:00 AM UTC

Biotest granted Kedrion exclusive rights to commercialize Bivigam in the U.S. The polyspecific IV immune globulin is marketed in the U.S. to treat primary humoral immunodeficiency. The companies decl...